<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta charset="utf-8" />
		<title>BCSC1718_S10_C01_p001_012</title>
		<link href="BCSC1718_S10_C01_p001_012-web-resources/css/idGeneratedStyles.css" rel="stylesheet" type="text/css" />
	</head>
	<body id="BCSC1718_S10_C01_p001_012" lang="en-US">
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer000" class="_idGenObjectStyleOverride-1">
			</div>
		</div>
		<div id="_idContainer001" class="Basic-Text-Frame">
			<p class="fm-only_fm-objectives-text">Upon completion of BCSC Section 10, <span class="CharOverride-1">Glaucoma,</span> the reader should be able to</p>
			<ul>
				<li class="fm-only_fm-objectives-bullet-list-first">state the epidemiologic features of glaucoma, including the social and economic impacts of the disease</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">list recent advances in the understanding of hereditary and genetic factors in glaucoma</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">describe the physiology of aqueous humor dynamics and the control of intraocular pressure (IOP)</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">describe the clinical evaluation of the glaucoma patient, including history and general examination, gonioscopy, optic nerve examination, and visual field</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">list the clinical features of the patient considered a glaucoma suspect</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">describe the clinical features, evaluation, and treatment of primary open-angle glaucoma and normal-tension glaucoma</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">list the various clinical features of and therapeutic approaches for the secondary open-angle glaucomas</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">state the underlying causes of the increased IOP in various forms of secondary open-angle glaucoma and the impact that these underlying causes have on management</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">describe the mechanisms and pathophysiology of primary angle-closure glaucoma</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">describe the pathophysiology of secondary angle-closure glaucoma, both with and without pupillary block</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">describe the pathophysiology of and therapy for primary congenital and juvenile-onset glaucomas</li>
				<li class="fm-only_fm-objectives-bullet-list-mid">describe the various classes of medical therapy for glaucoma, including efficacy, mechanism of action, and safety</li>
				<li class="fm-only_fm-objectives-bullet-list-last _idGenParaOverride-1">state the indications for, techniques used in, and complications of various laser and incisional surgical procedures for glaucoma </li>
			</ul>
			<p class="chapter-number"><span class="cn-chap">Chapter </span>1</p>
			<p class="chapter-title">Introduction to Glaucoma: Terminology, Epidemiology, and Heredity</p>
			<p class="h1 ParaOverride-1">Definitions</p>
			<div id="Chapt1_Top1">
			<p class="body-text--no-indent-">Glaucoma represents a group of diseases defined by a characteristic optic neuropathy that is consistent with remodeling of the connective tissue elements of the optic nerve head (also called the optic disc) and with loss of neural tissue associated with the eventual development of distinctive patterns of visual dysfunction. Although the <span class="italic">intraocular pressure (IOP)</span> level is one of the primary risk factors for development of glaucoma, it does not have a role in the definition of the disease; further, IOP of any level can have an impact on the risk of glaucoma.</p>
			<p class="body-text">Susceptibility to glaucoma is determined not only by the IOP, but also by the resilience of the optic nerve to the multiple pathogenic mechanisms involved in the neuropathy. Thus, in some individuals, progressive injury may occur at low IOP levels whereas in others with higher pressures, injury never occurs. When considering whether glau&#173;comatous damage is truly occurring in a patient with “normal” IOP, the ophthalmologist should take into account measurement artifacts and circadian variations in IOP. In most cases of glaucoma, it is presumed that the IOP is too high for proper functioning of the optic nerve axons and that lowering the pressure will stabilize the damage. However, <br />the optic nerve may continue to be damaged despite decreasing the IOP.</p>
			<p class="body-text">The term <span class="italic">preperimetric glaucoma</span> is sometimes used to denote glaucomatous changes in the optic nerve head in the absence of development of clinically detectable visual field damage.</p>
			<p class="h2 ParaOverride-2">Open-Angle, Angle-Closure, Primary, and Secondary Glaucomas</p>
			<p class="body-text--no-indent-">Traditionally, glaucoma has been classified as open-&#173;angle or angle-&#173;closure glaucoma and as primary or secondary (<span class="xref-table">Table&#160;1-1</span>). Distinguishing open-&#173;angle glaucoma from angle-&#173;closure is essential from a therapeutic standpoint (<span class="xref-figure">Fig&#160;1-1</span>), and each type of glaucoma is discussed in detail in Chapters&#160;4 and&#160;5; normal aqueous humor flow in the eye is illustrated in <span class="xref-figure">Figure&#160;1-2</span>. The concept of primary and secondary glaucoma, while useful, reflects our lack of understanding of the pathophysiologic mechanisms underlying the glaucomatous process. Open-&#173;angle glaucoma is traditionally classified as primary when there is no identifiable underlying anatomical cause of the events that led to obstruction of aqueous outflow and subsequent elevation of IOP. The etiology of the outflow obstruction is generally thought to be an abnormality in the extracellular matrix of the trabecular meshwork and in trabecular cells in the juxtacanalicular region, but other etiologies have been suggested. Glaucoma is classified as secondary when an abnormality is identified and a putative role in the pathogenesis of the disease can be ascribed to the abnormality. There are other approaches for classifying the glaucomas (eg, anatomical, gonioscopic, biochemical, molecular, and genetic), and each has its merit.</p>
			<p class="body-text">As knowledge of the mechanisms underlying the causes of glaucoma has grown, other schemes for classifying this disease have been proposed and the primary/secondary classification has become increasingly artificial. Classification of the glaucomas based on initial events and classification based on mechanisms of outflow obstruction are 2&#160;schemes that have gained increasing popularity (<span class="xref-table">Table&#160;1-2</span>).</p>
			<p class="reference-single ParaOverride-3">Casson RJ, Chidlow G, Wood JP, Crowston JG, Goldberg I. Definition of glaucoma: clinical and experimental concepts. <span class="italic">Clin Experiment Ophthalmol.</span> 2012;40(4):341–349.</p>
			<p class="h2">Combined-Mechanism Glaucoma</p>
			<p class="body-text--no-indent-">In combined-&#173;mechanism glaucoma, most commonly, the patient has undergone successful treatment for a narrow angle but continues to demonstrate reduced outflow facility and elevated IOP in the absence of peripheral anterior synechiae. Less commonly, secondary angle closure develops from other causes in a patient who has OAG. In this condition, IOP elevation can occur as a result of the following:</p>
			<ul>
				<li class="bullet-list-first">the intrinsic resistance of the trabecular meshwork to aqueous outflow in OAG</li>
				<li class="bullet-list-last ParaOverride-4">the direct anatomical obstruction of the filtering meshwork by synechiae in angle-&#173;closure glaucoma</li>
			</ul>
			</div>
			<p class="h1 ParaOverride-5">Epidemiologic Aspects of Glaucoma</p>
			<div id="Chapt1_Top2">
			<p class="h2-h1">Primary Open-Angle Glaucoma</p>
			<p class="h3-h2">Magnitude of the problem</p>
			<p class="body-text--no-indent-">Primary open-&#173;angle glaucoma (POAG) poses a significant public health problem. In the United States, the estimated prevalence of POAG in individuals older than 40&#160;years is 1.86% (95% confidence interval, 1.75%–1.96%), based on a meta-&#173;analysis of population-&#173;based studies. Applied to data from the 2000 US&#160;census, this percentage translates to nearly 2.22&#160;million Americans affected. Estimates based on the available data indicate that between 84,000 and 116,000 of these individuals have become bilaterally blind (best-&#173;corrected visual acuity ≤20/200 or visual field &lt;20°). With the rapidly aging US population, the number of POAG patients is estimated to increase by 50%, to 3.36&#160;million, <br />by 2020.</p>
			<p class="body-text">The World Health Organization (WHO) undertook an analysis of the literature to estimate the prevalence, incidence, and severity of the different types of glaucoma on a worldwide basis. Using data collected predominantly in the late 1980s and early 1990s, the WHO estimated the global population of persons with high IOP (&gt;21&#160;mm&#160;Hg) to be 104.5&#160;million. The incidence of POAG was estimated at 2.4&#160;million persons per year. Blindness prevalence for all types of glaucoma was estimated at more than 8&#160;million persons, with 4&#160;million cases caused by POAG. Glaucoma was theoretically calculated to account for 12.3% of cases of blindness; it is therefore the second leading cause of blindness worldwide, following cataract.</p>
			<p class="h3 ParaOverride-6">Prevalence</p>
			<p class="body-text--no-indent-">The estimated prevalence (the total number of individuals with a disease at a specific time) of POAG varies widely across population-&#173;based samples. For example, the Rotterdam Study (northern European population) shows a prevalence of 0.8%, while the Barbados Eye Study (Caribbean population) shows a prevalence of 7% in individuals older than 40&#160;years. In both of these studies, however, there is a significant increase in the prevalence of <br />POAG in older individuals, with estimates for persons in their 70s being generally 3 to 8&#160;times higher than estimates for persons in their 40s. Also, multiple population-&#173;based surveys have demonstrated a higher prevalence of POAG in specific ethnic groups. Among white persons aged 40&#160;years and older, a prevalence of between 1.1% and 2.1% has been reported. The prevalence among black persons and Latino persons is up to 4&#160;times higher compared with that among whites. Black individuals are also at greater risk of blindness due to POAG, and this risk increases with age: in persons aged 46–65&#160;years, the likelihood of blindness due to POAG is 15&#160;times higher among blacks than it is among whites.</p>
			<p class="reference-first">Friedman DS, Wolfs RC, O’Colmain BJ, et al. Prevalence of open-&#173;angle glaucoma among adults in the United States. <span class="italic">Arch Ophthalmol.</span> 2004;122(4):532–538.</p>
			<p class="reference-mid">Javitt JC, McBean AM, Nicholson GA, Babish JD, Warren JL, Krakauer H. Undertreatment of glaucoma among black Americans. <span class="italic">N&#160;Engl J&#160;Med.</span> 1991;325:1418–1422.</p>
			<p class="reference-last ParaOverride-3">Varma R, Ying Lai M, Francis BA, et al; Los Angeles Latino Eye Study Group. Prevalence of open-&#173;angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. <span class="italic">Ophthalmology.</span> 2004;111(8):1439–1448.</p>
			<p class="h3 ParaOverride-7">Incidence</p>
			<p class="body-text--no-indent-">The incidence (the number of new cases of a disease that develop during a specific period) of POAG has not been examined as much as the prevalence of POAG in population-&#173;based studies, and it varies widely. The Barbados Eye Study demonstrated, in a predominantly black population, a 4-year incidence of 2.2% in subjects older than 40&#160;years. A much lower incidence was demonstrated in the Visual Impairment Project (based in Melbourne, Australia), which found a 5-year incidence of 1.1% for definite and probable POAG. Similarly, the Rotterdam Study found a 5-year incidence of 1.8% for definite and probable POAG. The Rochester Epidemiology Project found an annual incidence of 14.5&#160;cases per 100,000 population (equivalent to a 5-year incidence of 0.72%) in Olmsted County, Minnesota.</p>
			<p class="h3 ParaOverride-7">Risk factors</p>
			<p class="body-text--no-indent-">In prospective studies, a number of risk factors have been found to be associated with progression of POAG. They include elevated IOP, reduced perfusion pressure, advanced age, positive family history, thin central corneas, and race/ethnicity (<span class="xref-table">Table&#160;1-3</span>). The role of gender and of various systemic factors (eg, diabetes mellitus, hypertension, atherosclerotic and ischemic vascular diseases) in the development of glaucoma has been widely debated, and currently available data are inconclusive.</p>
			<p class="body-text">In the assessment of elevated IOP, the clinician should keep in mind circadian variation in IOP, the importance of which is increasingly being recognized. Current evidence, obtained under sleep laboratory conditions, suggests that in most subjects, peak IOP occurs in the early-&#173;morning hours and is therefore not seen in the routine clinical <br />setting.</p>
			<p class="reference-first ParaOverride-8">Dueker DK, Singh K, Lin SC, et al. Corneal thickness measurement in the management of primary open-&#173;angle glaucoma: a report by the American Academy of Ophthalmology. <span class="italic">Ophthalmology.</span> 2007;114(9):1779–1787.</p>
			<p class="reference-mid">Leske MC, Connell AM, Wu SY, et al. Incidence of open-&#173;angle glaucoma: the Barbados Eye Studies. The Barbados Eye Studies Group. <span class="italic">Arch Ophthalmol.</span> 2001;119(1):89–95.</p>
			<p class="reference-last ParaOverride-3">Leske MC, Heijl A, Hyman L, et al. Predictors of long-term progression in the early manifest glaucoma trial. <span class="italic">Ophthalmology.</span> 2007;114(11):1965–1972.</p>
			<p class="h2">Primary Angle-&#173;Closure Glaucoma</p>
			<p class="h3-h2">Prevalence</p>
			<p class="body-text--no-indent-">The prevalence of primary angle-&#173;closure glaucoma (PACG) varies among different racial and ethnic groups. Among white populations in the United States and Europe, it is estimated at 0.1%. The prevalence in Inuit populations from the Arctic regions is 20 to 40&#160;times higher than that in white populations and is the highest known. Estimates for Asian populations vary widely, but available data suggest that the prevalence of PACG in most Asian population groups is between the prevalence in whites and in the Inuit. Some studies have suggested that the prevalence of PACG among blacks is similar to that among whites; most cases of PACG in black patients are chronic.</p>
			<p class="h3">Risk factors</p>
			<p class="body-text--no-indent-">The prevalence of PACG varies by sex as well as by race and ethnicity. Several population-&#173;based surveys show that women are at increased risk of PACG. Studies of normal eyes have shown that women have shallower anterior chambers than men. Older age is another risk factor. The depth and volume of the anterior chamber decrease with age, predisposing the eye to pupillary block. The prevalence of PACG with pupillary block thus increases with age. Acute PACG is most common between the ages of 55 and 65&#160;years, but it can occur in young adults and has been reported in children. Although PACG may occur in eyes with <br />any type of refractive error, the shallower anterior chamber depth of hyperopic eyes may predispose them to this disease. Plateau iris may be suspected when PACG is seen in myopic eyes. A positive family history of PACG may also increase the risk of this disease.</p>
			<p class="reference-first">Cho HK, Kee C. Population-&#173;based glaucoma prevalence studies in Asians. <span class="italic">Surv Ophthalmol.</span> 2014;59(4):434–447.</p>
			<p class="reference-mid">Epstein DL, Allingham RR, Schuman JS, eds. <span class="italic">Chandler and Grant’s Glaucoma.</span> 4th&#160;ed. Baltimore: Williams &amp; Wilkins; 1997:641–646.</p>
			<p class="reference-last ParaOverride-3">Ritch RM, Shields MB, Krupin T, eds. <span class="italic">The Glaucomas.</span> 2nd&#160;ed. St&#160;Louis: Mosby; 1996:753–765.</p>
			</div>
			<p class="h1">Genetics, Environmental Factors, and Glaucoma</p>
			<div id="Chapt1_Top3">
			<p class="body-text--no-indent-">The precise mechanism of inheritance of glaucoma is not clear. Many cases appear to have an autosomal dominant inheritance pattern that may be polygenic; the age of onset is late or variable; they demonstrate incomplete penetrance; and they may be substantially influenced by environmental factors. (See BCSC Section&#160;2, <span class="italic">Fundamentals and Principles of Ophthalmology,</span> Part&#160;III, Genetics, for detailed discussion of inheritance patterns.) A positive family history is a risk factor for the development of POAG. The prevalence of glaucoma among siblings of glaucoma patients is approximately 10%.</p>
			<p class="body-text">The first gene described for POAG, <span class="italic">GLC1A</span> (also called the trabecular meshwork inducible glucocorticoid response/myocilin gene <span class="italic">[TIGR/MYOC]</span>), codes for the TIGR protein and is a trabecular meshwork glucocorticoid gene, located on chromosome&#160;1. Mutations in <span class="italic">GLC1A</span> are present in 3% of the general OAG population. Additional OAG genes have been mapped, and many potential OAG genes are being explored. The percentage of genes known to be associated with specific types of glaucoma is small, largely because of the complex nature of the disease and because of the complicated interactions between multiple genetic loci and environmental factors (<span class="xref-table">Table&#160;1-4</span>). Researchers are increasingly applying genomewide scanning techniques in large cohorts of glaucoma subjects. These techniques may be useful for determining which regions of the genome are associated with glaucoma.</p>
			<p class="reference-first">Allingham RR, Liu Y, Rhee DJ. The genetics of primary open-&#173;angle glaucoma: a review. <span class="italic">Exp Eye Res.</span> 2009;88(4):837–844.</p>
			<p class="reference-mid">Stone EM, Fingert JH, Alward WL, et al. Identification of a gene that causes primary open angle glaucoma. <span class="italic">Science.</span> 1997;275(5300):668–670.</p>
			<p class="reference-last ParaOverride-3">Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT. Genetic risk of primary open-&#173;angle glaucoma: population-&#173;based familial aggregation study. <span class="italic">Arch Ophthalmol.</span> 1998;116(12):1640–1645.</p>
			<p class="h2">Environmental Factors</p>
			<p class="body-text--no-indent-">Evidence that environmental factors can play a role in the etiology of glaucoma arises from studies of twins and from analysis of the season of birth of glaucoma patients. If glaucoma were genetically determined, identical twins would theoretically share this trait more often than would fraternal twins. In the Finnish Twin Cohort Study, 3 of 29&#160;monozygotic twin pairs were concordant for POAG, compared with 1 of 79&#160;dizygotic twin pairs. Although a higher percentage of monozygotic twins was concordant for glaucoma, most of these twin pairs were not. These data suggest that while genetic factors contribute to the etiology of glaucoma, other factors, such as environmental influences, are important.</p>
			<p class="h2">Genetic Testing</p>
			<p class="body-text--no-indent-">In the future, the management of some glaucoma patients will involve testing of multiple, and potentially interacting, genetic loci. Rapid advances in genetic techniques allowing this type of testing have been made. Advances in the study of genetic diseases, however, require accurate categorization of individuals and families with specific phenotypes. By appropriately identifying families with strong histories of glaucoma, the practicing ophthalmologist has an opportunity to provide important information to researchers in genetics. The cooperation of the clinician is thus critical to the advancement of this vital area of research.</p>
		</div>
		</div>
		<div id="_idContainer002" class="Basic-Text-Frame">
			<table id="table001" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-1" />
					<col class="_idGenTableRowColumn-2" />
					<col class="_idGenTableRowColumn-3" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="3">
							<p class="table-title"><span class="table-number">Table 1-1</span> Classification of the Glaucomas</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Type</p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Characteristics</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-3" colspan="3">
							<p class="table-head">Open-angle glaucoma and related diagnoses</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-7">
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Primary open-angle glaucoma (POAG)</p>
						</td>
						<td class="Basic-Table CellOverride-4" />
						<td class="Basic-Table CellOverride-4">
							<p class="table-body">Not associated with known ocular or systemic disorders that cause increased resistance to aqueous outflow or damage to optic nerve; usually associated with elevated IOP</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Normal-tension glaucoma (NTG)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Considered to be within the continuum of POAG; term often used when IOP is within the statistically normal range </p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Juvenile open-angle glaucoma (JOAG)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Term often used when open-angle glaucoma is diagnosed at a young age (typically 4–35&#160;years of age)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Ocular hypertension (OHT) </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Elevated IOP in the absence of optic nerve, retinal nerve fiber layer, or visual field abnormalities</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Glaucoma suspect</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Optic nerve head appearance or visual field suggestive of glaucoma regardless of IOP</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Secondary open-angle glaucoma</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Increased resistance to trabecular meshwork outflow associated with other conditions (eg, pigmentary, phacolytic, steroid-induced, pseudoexfoliation, angle-recession, and uveitic glaucomas)</p>
							<p class="table-body">Elevated episcleral venous pressure (eg, carotid-cavernous sinus fistula, Sturge-Weber, idiopathic)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-6" colspan="3">
							<p class="table-body"><span class="CharOverride-2">Angle-closure glaucoma</span> (see Fig 1-1)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Primary angle-closure suspect (PACS)</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Narrow angle with no signs of trabecular meshwork or optic nerve damage </p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Primary angle closure (PAC)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Narrow angle with elevated IOP or PAS but no optic nerve damage</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Primary angle-closure glaucoma (PACG)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Narrow angle with elevated IOP or PAS with evidence of optic nerve damage</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Primary angle closure without pupillary block (plateau iris)</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">An anatomical variation in the iris root in which narrowing of the angle occurs independent of pupillary block </p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-8">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Chronic angle closure </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">IOP elevation caused by variable portions of anterior chamber angle being permanently closed by PAS </p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-12">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Secondary angle closure with pupillary block </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Pupillary block occurs as a result of a mechanism other than the anatomical configuration of the anterior segment (eg, intumescent lens, air/gas/silicone oil bubble, secluded pupil, or DSAEK)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-9">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Secondary angle closure without pupillary block </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Posterior pushing mechanism: lens–iris interface pushed forward (eg, posterior segment tumor, malignant glaucoma, uveal effusion, intravitreal injections)</p>
							<p class="table-body">Anterior pulling mechanism: iris pulled forward to form PAS (eg, iridocorneal endothelial syndrome, neovascular glaucoma, inflammation)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-10">
						<td class="Basic-Table CellOverride-6" colspan="3">
							<p class="table-head">Childhood glaucoma</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-11">
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Primary congenital glaucoma (PCG)</p>
						</td>
						<td class="Basic-Table CellOverride-7" />
						<td class="Basic-Table CellOverride-7">
							<p class="table-body">Presents at birth or within the first few years of life </p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-12">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Glaucoma associated with congenital anomalies </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Associated with ocular disorders (eg, Axenfeld-Rieger syndrome, aniridia)</p>
							<p class="table-body">Associated with systemic disorders (eg, Sturge-Weber syndrome, neurofibromatosis 1)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-13">
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">Secondary glaucoma in infants and children</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">Associated with acquired disorders (eg, inflammation, retinoblastoma, trauma)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9" colspan="3">
							<p class="table-footnote ParaOverride-9">DSAEK = Descemet-stripping automated endothelial keratoplasty; IOP = intraocular pressure; PAS&#160;= peripheral anterior synechiae.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer005">
				<div id="_idContainer003" class="_idGenObjectStyleOverride-2">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S10_C01_p001_012-web-resources/image/KIN00602.png" alt="" />
				</div>
				<div id="_idContainer004" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-1</span> <span class="figure-caption-italic">1,</span>&#160;The pupil is constricted and the angle is open. <span class="figure-caption-italic">2,</span>&#160;The pupil is in the mid-&#173;dilated position. Pupillary block is maximal in this position and, as a result, the iris is bowed anteriorly and the angle narrows. <span class="figure-caption-italic">3,</span>&#160;The pupil is completely dilated, and pupillary block is diminished, with a return to a flatter iris configuration. If full-blown angle closure occurs, the iris may stay in the mid-&#173;dilated position until the angle-&#173;closure attack is broken. <span class="figure-source-note">(Illustration by Cyndie C.&#160;H. Wooley.)</span></p>
				</div>
			</div>
		</div>
		<div class="_idGenObjectLayout-1">
			<div id="_idContainer008">
				<div id="_idContainer006" class="_idGenObjectStyleOverride-2">
					<img class="_idGenObjectAttribute-1" src="BCSC1718_S10_C01_p001_012-web-resources/image/KIN00523.png" alt="" />
				</div>
				<div id="_idContainer007" class="Basic-Text-Frame">
					<p class="figure-caption"><span class="figure-number">Figure 1-2</span> Diagrammatic cross section of the anterior segment of the normal eye, showing the site of aqueous production (ciliary body), sites of conventional aqueous outflow (trabecular meshwork–Schlemm canal system and episcleral venous plexus; <span class="figure-caption-italic">red arro</span><span class="figure-caption-italic">w</span>), and the uveoscleral outflow pathway <span class="figure-caption-italic">(green arrow).</span> <span class="figure-source-note">(Illustration by Cyndie C.&#160;H. Wooley.)</span></p>
				</div>
			</div>
		</div>
		<div id="_idContainer009" class="Basic-Text-Frame">
			<table id="table002" class="No-Table-Style TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-15" />
					<col class="_idGenTableRowColumn-16" />
					<col class="_idGenTableRowColumn-17" />
					<col class="_idGenTableRowColumn-18" />
					<col class="_idGenTableRowColumn-19" />
					<col class="_idGenTableRowColumn-20" />
					<col class="_idGenTableRowColumn-16" />
					<col class="_idGenTableRowColumn-21" />
					<col class="_idGenTableRowColumn-16" />
					<col class="_idGenTableRowColumn-22" />
				</colgroup>
				<tbody>
					<tr class="No-Table-Style _idGenTableRowColumn-4">
						<td class="No-Table-Style CellOverride-1 _idGenCellOverride-1" colspan="10">
							<p class="table-title"><span class="table-number">Table 1-2</span> Classification of the Glaucomas Based on Mechanisms of Outflow Obstruction*</p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-23">
						<td class="No-Table-Style CellOverride-10" colspan="4">
							<p class="table-subhead"><span class="CharOverride-3">Open-Angle Glaucoma Mechanisms</span></p>
						</td>
						<td class="No-Table-Style CellOverride-10" />
						<td class="No-Table-Style CellOverride-10" colspan="3">
							<p class="table-subhead"><span class="CharOverride-3">Angle-Closure Glaucoma Mechanisms</span></p>
						</td>
						<td class="No-Table-Style CellOverride-10" />
						<td class="No-Table-Style CellOverride-10" />
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-8">
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head"><span class="CharOverride-3">Pretrabecular</span></p>
							<p class="table-column-head"><span class="CharOverride-3">(Membrane Overgrowth)</span></p>
						</td>
						<td class="No-Table-Style CellOverride-11" />
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head"><span class="CharOverride-3">Trabecular</span></p>
						</td>
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head"><span class="CharOverride-3">Posttrabecular</span></p>
						</td>
						<td class="No-Table-Style CellOverride-11" />
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head"><span class="CharOverride-3">Anterior (</span><span class="math CharOverride-4">“</span><span class="CharOverride-3">Pulling</span><span class="math CharOverride-4">”</span><span class="CharOverride-3">)</span></p>
						</td>
						<td class="No-Table-Style CellOverride-11" />
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head"><span class="CharOverride-3">Posterior (</span><span class="math CharOverride-4">“</span><span class="CharOverride-3">Pushing</span><span class="math CharOverride-4">”</span><span class="CharOverride-3">)</span></p>
						</td>
						<td class="No-Table-Style CellOverride-11" />
						<td class="No-Table-Style CellOverride-11">
							<p class="table-column-head"><span class="CharOverride-3">Developmental Anomalies of</span></p>
							<p class="table-column-head"><span class="CharOverride-3">Anterior Chamber Angle</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-24">
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body"><span class="CharOverride-3">Fibrovascular membrane (neovascular glaucoma)</span></p>
							<p class="table-body"><span class="CharOverride-3">Endothelial layer, often with Descemet-like membrane </span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Iridocorneal endothelial syndrome</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Posterior polymorphous dystrophy</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Penetrating and nonpenetrating trauma</span></p>
							<p class="table-body"><span class="CharOverride-3">Epithelial downgrowth</span></p>
							<p class="table-body"><span class="CharOverride-3">Fibrous ingrowth</span></p>
							<p class="table-body"><span class="CharOverride-3">Inflammatory membrane</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Fuchs heterochromic uveitis</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Luetic interstitial keratitis</span></p>
						</td>
						<td class="No-Table-Style CellOverride-12" />
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body"><span class="CharOverride-3">Idiopathic</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Primary open-angle glaucoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Juvenile open-angle glaucoma</span></p>
							<p class="table-body"><span class="CharOverride-3">“Clogging” of trabecular meshwork</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Red blood cells</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Hemorrhagic glaucoma</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Ghost cell glaucoma</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Sickled red blood cells</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Macrophages</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Hemolytic glaucoma</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Phacolytic glaucoma</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Melanomalytic glaucoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Neoplastic cells</span></p>
							<p class="table-indent-2 ParaOverride-11"><span class="CharOverride-3">Primary ocular tumors</span></p>
							<p class="table-body-ol2 ParaOverride-12"><span class="CharOverride-3">Neoplastic tumors</span></p>
							<p class="table-body-ol2 ParaOverride-12"><span class="CharOverride-3">Juvenile xanthogranuloma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Pigment particles</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Pigmentary glaucoma</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Pseudoexfoliation syndrome (glaucoma capsulare)</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Melanoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Protein</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Uveitis</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Lens-induced glaucoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Viscoelastic agents</span></p>
							<p class="table-body"><span class="CharOverride-3">Alterations of the trabecular meshwork</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Steroid-induced glaucoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Edema/inflammation</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Uveitis (trabeculitis)</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Scleritis and episcleritis</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Alkali burns</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Trauma (angle recession)</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Laser trabeculoplasty</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Intraocular foreign bodies (hemosiderosis, chalcosis)</span></p>
						</td>
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body"><span class="CharOverride-3">Obstruction of Schlemm canal, eg, collapse at canal</span></p>
							<p class="table-body"><span class="CharOverride-3">Elevated episcleral venous pressure</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Carotid-cavernous fistula</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Cavernous sinus thrombosis</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Retrobulbar tumors</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Thyroid eye disease</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Superior vena cava obstruction</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Mediastinal tumors</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Sturge-Weber syndrome</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Familial episcleral venous pressure elevation</span></p>
						</td>
						<td class="No-Table-Style CellOverride-12" />
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body"><span class="CharOverride-3">Contracture of membranes</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Neovascular  glaucoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Iridocorneal endothelial syndrome</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Posterior polymorphous dystrophy</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Penetrating and nonpenetrating trauma</span></p>
							<p class="table-body"><span class="CharOverride-3">Consolidation of inflammatory products</span></p>
						</td>
						<td class="No-Table-Style CellOverride-12" />
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body"><span class="CharOverride-3">With pupillary block</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Primary pupillary block glaucoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Lens-induced mechanisms</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Phacomorphic lens</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Ectopia lentis</span></p>
							<p class="table-indent-2 ParaOverride-13"><span class="CharOverride-3">Aphakic vitreous or silicone oil block</span></p>
							<p class="table-body ParaOverride-13"><span class="CharOverride-3">Posterior synechiae</span></p>
							<p class="table-body ParaOverride-11"><span class="CharOverride-3">Pseudophakia (esp. with ACIOL)</span></p>
							<p class="table-body ParaOverride-11"><span class="CharOverride-3">Uveitis with iris bombé</span></p>
							<p class="table-body"><span class="CharOverride-3">Without pupillary block</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Ciliary block (malignant) glaucoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Lens-induced mechanisms</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Phacomorphic lens</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Ectopia lentis</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Following lens extraction (forward vitreous shift)</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Anterior rotation of ciliary body</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Uveal effusion </span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Central retinal vein occlusion</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Panretinal photocoagulation</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Scleral buckling</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Annular choroidal detachment</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Intraocular tumors</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Melanoma</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Retinoblastoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Cysts of the iris and ciliary body </span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Persistent fetal vasculature</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Retinopathy of prematurity </span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Plateau iris syndrome</span></p>
						</td>
						<td class="No-Table-Style CellOverride-12" />
						<td class="No-Table-Style CellOverride-12">
							<p class="table-body"><span class="CharOverride-3">Incomplete development of trabecular meshwork–Schlemm canal and iris</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Congenital (infantile) glaucoma</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Anterior segment dysgenesis</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Axenfeld-Rieger syndrome</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Peters anomaly</span></p>
							<p class="table-indent-2"><span class="CharOverride-3">Aniridia</span></p>
							<p class="table-indent-1 ParaOverride-10"><span class="CharOverride-3">Glaucomas associated with other developmental anomalies</span></p>
						</td>
					</tr>
					<tr class="No-Table-Style _idGenTableRowColumn-14">
						<td class="No-Table-Style CellOverride-9" colspan="10">
							<p class="table-footnote">ACIOL = anterior chamber intraocular lens.</p>
							<p class="table-footnote">*Clinical examples cited in this table do not represent an inclusive list of the glaucomas.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer010" class="Basic-Text-Frame">
			<table id="table003" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-25" />
					<col class="_idGenTableRowColumn-26" />
					<col class="_idGenTableRowColumn-27" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="3">
							<p class="table-title"><span class="table-number">Table 1-3</span> Risk Factors for Glaucomatous Progression</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-5">
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Risk Factor </p>
						</td>
						<td class="Basic-Table CellOverride-2" />
						<td class="Basic-Table CellOverride-2">
							<p class="table-column-head">Prospective Study</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Increasing age </p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">AGIS, CIGTS, EGPS, EMGT, OHTS</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-13">
							<p class="table-body">African ancestry </p>
						</td>
						<td class="Basic-Table CellOverride-13" />
						<td class="Basic-Table CellOverride-13">
							<p class="table-body">AGIS, CIGTS, CNTGS, OHTS (univariate)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Visual field severity </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">AGIS, EGPS, EMGT, OHTS</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Diabetes mellitus</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">AGIS, OHTS (protective)</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Disc hemorrhage </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">CNTGS, EMGT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Follow-up IOP</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">CNTGS, EMGT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Cup–disc ratio </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">EGPS, OHTS</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Central corneal thickness </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">EGPS, OHTS</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Pseudoexfoliation</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">EMGT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Initial IOP </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">EMGT</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Female sex </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">CNTGS</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Male sex </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">AGIS</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Perfusion pressure</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">BES, LALES</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-28">
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">Hispanic ethnicity</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">LALES</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-29">
						<td class="Basic-Table CellOverride-9" colspan="3">
							<p class="table-footnote ParaOverride-9">AGIS = Advanced Glaucoma Intervention Study; BES = Barbados Eye Study; CIGTS = Collaborative Initial Glaucoma Treatment Study; CNTGS = Collaborative Normal-Tension Glaucoma Study; EGPS&#160;=&#160;European Glaucoma Prevention Study; EMGT = Early Manifest Glaucoma Trial; LALES = Los Angeles Latino Eye Study; OHTS = Ocular Hypertension Treatment Study.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
		<div id="_idContainer011" class="Basic-Text-Frame">
			<table id="table004" class="Basic-Table TableOverride-1">
				<colgroup>
					<col class="_idGenTableRowColumn-30" />
					<col class="_idGenTableRowColumn-31" />
					<col class="_idGenTableRowColumn-32" />
					<col class="_idGenTableRowColumn-33" />
					<col class="_idGenTableRowColumn-34" />
					<col class="_idGenTableRowColumn-33" />
					<col class="_idGenTableRowColumn-35" />
					<col class="_idGenTableRowColumn-33" />
					<col class="_idGenTableRowColumn-36" />
				</colgroup>
				<tbody>
					<tr class="Basic-Table _idGenTableRowColumn-4">
						<td class="Basic-Table CellOverride-1 _idGenCellOverride-1" colspan="9">
							<p class="table-title"><span class="table-number">Table 1-4</span> Currently Mapped Glaucoma Genes</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-37">
						<td class="Basic-Table CellOverride-14">
							<p class="table-column-head">Locus</p>
						</td>
						<td class="Basic-Table CellOverride-14" />
						<td class="Basic-Table CellOverride-14">
							<p class="table-column-head">Chromosome Location </p>
						</td>
						<td class="Basic-Table CellOverride-14" />
						<td class="Basic-Table CellOverride-14">
							<p class="table-column-head">Phenotype</p>
						</td>
						<td class="Basic-Table CellOverride-14" />
						<td class="Basic-Table CellOverride-14">
							<p class="table-column-head">Inheritance Pattern</p>
						</td>
						<td class="Basic-Table CellOverride-14" />
						<td class="Basic-Table CellOverride-14">
							<p class="table-column-head">Gene</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-6">
						<td class="Basic-Table CellOverride-3">
							<p class="table-body"><span class="CharOverride-5">GLC1A</span></p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">1q23</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">JOAG and adult POAG</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-3" />
						<td class="Basic-Table CellOverride-3">
							<p class="table-body"><span class="CharOverride-5">TIGR/MYOC</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-13">
							<p class="table-body"><span class="CharOverride-5">GLC1B</span></p>
						</td>
						<td class="Basic-Table CellOverride-13" />
						<td class="Basic-Table CellOverride-13">
							<p class="table-body">2cen-q13</p>
						</td>
						<td class="Basic-Table CellOverride-13" />
						<td class="Basic-Table CellOverride-13">
							<p class="table-body">NTG, adult POAG</p>
						</td>
						<td class="Basic-Table CellOverride-13" />
						<td class="Basic-Table CellOverride-13">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-13" />
						<td class="Basic-Table CellOverride-13">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC1C</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">3q21-24</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Adult POAG</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC1D</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">8q23</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Adult POAG</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC1E</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">10P15-14</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">NTG, adult POAG</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">OPTN</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC1F</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">7q35</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Adult POAG</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC1G</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">5q22</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Adult POAG</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant, complex</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">WDR36</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC1I</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">15q11-q13</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Adult POAG</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Complex</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC1J</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">9q22</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Early POAG</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC1K</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">20p12</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Early POAG</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GPDS1</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">7q35-q36</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">PDS</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC3A</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">2p21</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Congenital</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Recessive</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">CYP1B1</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC3B</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">1p36</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Congenital</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Recessive</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC3C</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">14q24.3</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Congenital</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Recessive</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">GLC3D</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">14q24.3</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Congenital</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Recessive</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">NNO1</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">11p</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Nanophthalmos</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">VMD2</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">11q12</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Nanophthalmos</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">MFRP</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">11q23</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Nanophthalmos</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Recessive</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">RIEG1</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">4q25</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Rieger syndrome</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">PITX2</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">RIEG2</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">13q14</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Rieger syndrome</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">IRID1</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">6p25</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Iridogoniodysgenesis</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">FOXC1</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">7q35 </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">PDS</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">—</p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-23">
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">NPS</span></p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">9q34 </p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Nail-patella syndrome</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body">Dominant</p>
						</td>
						<td class="Basic-Table CellOverride-5" />
						<td class="Basic-Table CellOverride-5">
							<p class="table-body"><span class="CharOverride-5">LMX1B</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-28">
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">15q24</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body">PXE</p>
						</td>
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8" />
						<td class="Basic-Table CellOverride-8">
							<p class="table-body"><span class="CharOverride-5">LOXL1</span></p>
						</td>
					</tr>
					<tr class="Basic-Table _idGenTableRowColumn-14">
						<td class="Basic-Table CellOverride-9" colspan="9">
							<p class="table-footnote ParaOverride-9">JOAG = juvenile open-angle glaucoma; NTG = normal-tension glaucoma; PDS = pigment dispersion syndrome; POAG = primary open-angle glaucoma; PXE = pseudoexfoliation.</p>
						</td>
					</tr>
				</tbody>
			</table>
		</div>
	</body>
</html>
